Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Microvascular Invasion (MVI)”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableLooking for participantsNCT07170345
What this trial is testing

Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)Microvascular Invasion (MVI)
Chinese Academy of Sciences 400
Not applicableUnknownNCT05889949
What this trial is testing

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Who this might be right for
RadiomicsHepatocellular Carcinoma (HCC)Transcatheter Arterial Chemoembolization (TACE)+2 more
Sun Yat-sen University 200
Testing effectiveness (Phase 2)UnknownNCT04911959
What this trial is testing

Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Second Affiliated Hospital, School of Medicine, Zhejiang University 50
Large-scale testing (Phase 3)UnknownNCT02436902
What this trial is testing

Adjuvant Therapies for Patients With HCC and MVI

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 240
Large-scale testing (Phase 3)UnknownNCT03192618
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 290
Not applicableNot Yet RecruitingNCT06449846
What this trial is testing

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma ResectableSurgeryRecurrence
Zhujiang Hospital 152
Testing effectiveness (Phase 2)Study completedNCT03575806
What this trial is testing

Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection

Who this might be right for
Hepatocellular CarcinomaMalignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Early research (Phase 1)UnknownNCT02587884
What this trial is testing

Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 180
Not applicableStudy completedNCT00963612
What this trial is testing

Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 80
Not applicableStudy completedNCT06760494
What this trial is testing

Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability

Who this might be right for
HCC - Hepatocellular CarcinomaMicrovascular Invasion (MVI)
Chinese PLA General Hospital 250
Not applicableUnknownNCT02537158
What this trial is testing

Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Chinese Academy of Medical Sciences 90
Large-scale testing (Phase 3)UnknownNCT04053972
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 377
Not applicableStudy completedNCT04891874
What this trial is testing

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 76